Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

224.53B

Market cap224.53B

Price-Earnings ratio

12.07

Price-Earnings ratio12.07

Dividend yield

2.39%

Dividend yield2.39%

Average volume

8.63M

Average volume8.63M

High today

$51.25

High today$51.25

Low today

$51.02

Low today$51.02

Open price

$50.00

Open price$50.00

Volume

141.00K

Volume141.00K

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Nasdaq 1h

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

Key Points Amgen wants a slice of the weight loss drug market. Its candidate for capturing that market share might not be up to the task. Its competitors are...

Simply Wall St 7h

Novo Nordisk Stock Looks Undervalued On Cash Flow And Earnings

Novo Nordisk stock is coming off a weak patch over the past three years, yet current valuation checks and an intrinsic value estimate suggest the market price m...

TipRanks 21h

Novo Nordisk’s ZEUS Trial Reaches Completion: What It Could Mean for NVO Investors

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident i...

Analyst ratings

57%

of 37 ratings

Buy

37.8%

Hold

56.8%

Sell

5.4%

More NVO News

TipRanks 2d

Novo Nordisk Boosts Treasury Stock as 2026 Share Buyback Passes DKK 7.1 Billion

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

The Motley Fool 5d

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors?

GLP-1 drugs for weight loss are such a booming business that it was inevitable the major manufacturers of these wonder drugs would eventually end up in court. T...

TipRanks 5d

Novo Nordisk Pursues Injunction to Block Eli Lilly’s Advertisements

Novo Nordisk (NVO) has escalated its feud with rival drug maker Eli Lilly (LLY) by seeking a court injunction to immediately block Lilly’s weight-loss drug ad...

Seeking Alpha 5d

Novo files injunction to block Lilly’s weight-loss drug ads

Novo Nordisk (NVO) on Friday said it filed a preliminary injunction to immediately block Eli Lilly (LLY) from running obesity and diabetes drug advertisements i...

Simply Wall St 6d

Novo Nordisk Faces A Fair Value Debate, Is The Stock A Bargain?

Novo Nordisk (NYSE:NVO) shares closed at US$48.18, with recent returns mixed, including a decline over the past week and gains over the past month and past 3 mo...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.